These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3556 related articles for article (PubMed ID: 31282096)

  • 41. Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase.
    Xiong Q; Huang Z; Xin L; Qin B; Zhao X; Zhang J; Shi W; Yang B; Zhang G; Hu Y
    Cancer Immunol Immunother; 2021 Mar; 70(3):713-720. PubMed ID: 32910245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy.
    Guo D; Li M; Chen D; Jing W; Zhu H; Fu L; Kong L; Yue J; Yu J
    Future Oncol; 2019 Feb; 15(6):625-635. PubMed ID: 30430864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.
    Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    Oncotarget; 2017 Jan; 8(2):2329-2341. PubMed ID: 27911876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma.
    Aktepe OH; Güner G; Güven DC; Şahin TK; Ardıç FS; Yüce D; Yalçın Ş; Erman M
    Turk J Med Sci; 2021 Apr; 51(2):757-765. PubMed ID: 33350295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
    Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
    Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Impact of the Pretreatment or Posttreatment NLR and PLR on the Response of First Line Chemotherapy and the Outcomes in Patients with Advanced Non-small Cell Lung Cancer].
    Yi F; Gu Y; Chen S; Liu Y; Yin W; Zhang Y; Cao B
    Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):481-492. PubMed ID: 29945708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
    Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L
    BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy.
    Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
    Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
    World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab.
    Roussel E; Kinget L; Verbiest A; Debruyne PR; Baldewijns M; Van Poppel H; Albersen M; Beuselinck B
    Urol Oncol; 2021 Apr; 39(4):239.e17-239.e25. PubMed ID: 33485762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities.
    Chen Z; Zhao G; Chen F; Xia J; Jiang L
    BMC Cancer; 2019 Apr; 19(1):329. PubMed ID: 30961549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
    Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer.
    Matsubara S; Mabuchi S; Takeda Y; Kawahara N; Kobayashi H
    PLoS One; 2021; 16(5):e0248871. PubMed ID: 33989285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of neutrophil-lymphocyte and platelet-lymphocyte ratio on antiEGFR and bevacizumab efficacy in metastatic colorectal cancer.
    Dogan E; Bozkurt O; Sakalar T; Derin S; Inanc M; Ozkan M
    J BUON; 2019; 24(5):1861-1869. PubMed ID: 31786848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer.
    Takeda T; Takeuchi M; Saitoh M; Takeda S
    Thorac Cancer; 2018 Oct; 9(10):1291-1299. PubMed ID: 30126063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
    Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
    Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hematologic Markers of Lung Metastasis in Stage IV Colorectal Cancer.
    Abu-Shawer M; Abu-Shawer O; Souleiman M; Akkawi M; Alshakhatreh O; Altamimi T; Al-Omari A; Al-Hussaini M
    J Gastrointest Cancer; 2019 Sep; 50(3):428-433. PubMed ID: 29589285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma.
    Xia WK; Liu ZL; Shen D; Lin QF; Su J; Mao WD
    World J Surg Oncol; 2016 Apr; 14():127. PubMed ID: 27125872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
    Yang J; Xu H; Guo X; Zhang J; Ye X; Yang Y; Ma X
    Sci Rep; 2018 Feb; 8(1):3044. PubMed ID: 29445100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 178.